You are here

TOPLINE

Singapore Medical Group in the pink of health

The Catalist-listed company today has a market capitalisation of over S$200 million, and has been profitable since FY2016.

BT_20181022_NSTOPLINE22_3595278.jpg
"We have grown through a series of astute investments and earnings accretive acquisitions. We had to do that cautiously, by making difficult decisions because we had little room for error." - SMG chief executive officer Dr Beng Teck Liang.

THESE days Singapore Medical Group (SMG) barely resembles the once ailing entity that it was.

In 2013, the Catalist-listed group faced significant headwinds and losses due to the changing medical landscape in Singapore: declining medical tourism, changing economics of healthcare and...

sentifi.com

Market voices on: